TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Umbilical Cord Clamping and Infant Iron Status
Brief Summary: The aim of the study was to determine whether delayed umbilical cord clamping, as compared to early umbilical cord clamping, improves infant iron status at 6 months of age.


Options:
A: Arm Label: immediate umbilical cord clamping; Type: ACTIVE_COMPARATOR; Interventions: Procedure: immediate umbilical cord clamping | Arm Label: Milking the umbilical cord at birth; Type: EXPERIMENTAL; Interventions: Procedure: Milking the umbilical cord at birth | Intervention Type: PROCEDURE; Name: Milking the umbilical cord at birth; Assigned to Arm(s): Milking the umbilical cord at birth | Intervention Type: PROCEDURE; Name: immediate umbilical cord clamping; Assigned to Arm(s): immediate umbilical cord clamping
B: Arm Label: Early cord clamping (ECC); Type: OTHER; Interventions: Procedure: Early (≤30 seconds) cord clamping | Arm Label: Delayed cord clamping (DCC); Type: OTHER; Interventions: Procedure: Delayed (≤180 seconds) cord clamping | Intervention Type: PROCEDURE; Name: Early (≤30 seconds) cord clamping; Assigned to Arm(s): Early cord clamping (ECC) | Intervention Type: PROCEDURE; Name: Delayed (≤180 seconds) cord clamping; Assigned to Arm(s): Delayed cord clamping (DCC)
C: Arm Label: Early umbilical cord clamping (control); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Delayed umbilical cord clamping; Type: EXPERIMENTAL; Interventions: Procedure: Delayed umbilical cord clamping | Intervention Type: PROCEDURE; Name: Delayed umbilical cord clamping; Assigned to Arm(s): Delayed umbilical cord clamping
D: Arm Label: 1-Delayed Cord Clamping (DCC); Type: EXPERIMENTAL; Interventions: Procedure: delayed umbilical cord clamping | Arm Label: 2-Immediate Cord Clamping (ICC); Type: ACTIVE_COMPARATOR; Interventions: Other: Immediate cord clamping | Intervention Type: PROCEDURE; Name: delayed umbilical cord clamping; Assigned to Arm(s): 1-Delayed Cord Clamping (DCC) | Intervention Type: OTHER; Name: Immediate cord clamping; Assigned to Arm(s): 2-Immediate Cord Clamping (ICC)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Umbilical Cord Clamping and Infant Iron Status
Brief Summary: The aim of the study was to determine whether delayed umbilical cord clamping, as compared to early umbilical cord clamping, improves infant iron status at 6 months of age.


Options:
A: Arm Label: Early umbilical cord clamping (control); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Delayed umbilical cord clamping; Type: EXPERIMENTAL; Interventions: Procedure: Delayed umbilical cord clamping | Intervention Type: PROCEDURE; Name: Delayed umbilical cord clamping; Assigned to Arm(s): Delayed umbilical cord clamping
B: Intervention Type: DIETARY_SUPPLEMENT; Name: Daminaide 995 - SuppleFem Sprinkles; Assigned to Arm(s): N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Materna; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Ferrous fumarate (iron), Dietary Supplement: folic acid | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Ferrous fumarate (iron); Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: folic acid; Assigned to Arm(s): 1, 2
D: Intervention Type: DRUG; Name: Nutritional supplements; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An RCT to Evaluate the Effect of Home-Based Peer Support on Maternal-Infant Interaction, Infant Health Outcomes, and Postpartum Depression
Brief Summary: The objective of this study is to examine the impact of a home-based peer support intervention for mothers affected by postpartum depression (PPD) and for their infants.


Options:
A: Arm Label: Breastfeeding Clinic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Breastfeeding Clinic | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Clinic; Assigned to Arm(s): Breastfeeding Clinic
B: Arm Label: New breastfeeding programme; Type: EXPERIMENTAL; Interventions: Other: New Breastfeeding Counselling | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: OTHER; Name: New Breastfeeding Counselling; Assigned to Arm(s): New breastfeeding programme | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
C: Arm Label: Durham Connects Eligible Group; Type: EXPERIMENTAL; Interventions: Other: Durham Connects | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Durham Connects; Assigned to Arm(s): Durham Connects Eligible Group
D: Arm Label: mci guidance & peer social support; Type: EXPERIMENTAL; Interventions: Behavioral: mci guidance peer support | Arm Label: peer social support; Type: SHAM_COMPARATOR; Interventions: Behavioral: mci guidance peer support | Intervention Type: BEHAVIORAL; Name: mci guidance peer support; Assigned to Arm(s): mci guidance & peer social support, peer social support

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An RCT to Evaluate the Effect of Home-Based Peer Support on Maternal-Infant Interaction, Infant Health Outcomes, and Postpartum Depression
Brief Summary: The objective of this study is to examine the impact of a home-based peer support intervention for mothers affected by postpartum depression (PPD) and for their infants.


Options:
A: Arm Label: Philani Intervention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Program | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Philani Intervention Program; Assigned to Arm(s): Philani Intervention Program
B: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A
C: Arm Label: mci guidance & peer social support; Type: EXPERIMENTAL; Interventions: Behavioral: mci guidance peer support | Arm Label: peer social support; Type: SHAM_COMPARATOR; Interventions: Behavioral: mci guidance peer support | Intervention Type: BEHAVIORAL; Name: mci guidance peer support; Assigned to Arm(s): mci guidance & peer social support, peer social support
D: Arm Label: Enhanced Intervention; Type: EXPERIMENTAL; Interventions: Other: Enhanced Intervention | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced Intervention | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants


Options:
A: Arm Label: Lactobacillus reuteri; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus reuteri | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics
C: Intervention Type: DRUG; Name: Mixture of probiotic bacteria and prebiotic oligosaccharide; Assigned to Arm(s): N/A
D: Arm Label: daily probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri DSM 17938, Dietary Supplement: Bifidobacterium longum infantis | Arm Label: weekly probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri DSM 17938, Dietary Supplement: Bifidobacterium longum infantis | Arm Label: bi-weekly probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri DSM 17938, Dietary Supplement: Bifidobacterium longum infantis | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri DSM 17938; Assigned to Arm(s): bi-weekly probiotic, daily probiotic, weekly probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Bifidobacterium longum infantis; Assigned to Arm(s): bi-weekly probiotic, daily probiotic, weekly probiotic

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants


Options:
A: Intervention Type: DRUG; Name: Mixture of probiotic bacteria and prebiotic oligosaccharide; Assigned to Arm(s): N/A
B: Arm Label: Lreuteri; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lreuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lreuteri; Assigned to Arm(s): Lreuteri | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1 = Tested product; Type: ACTIVE_COMPARATOR; Interventions: Other: 1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®) | Arm Label: 2 = Control product; Type: SHAM_COMPARATOR; Interventions: Other: 2-Non fermented dairy product (control) | Intervention Type: OTHER; Name: 1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®); Assigned to Arm(s): 1 = Tested product | Intervention Type: OTHER; Name: 2-Non fermented dairy product (control); Assigned to Arm(s): 2 = Control product
D: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus fermentum | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Follow on formula without probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus fermentum; Assigned to Arm(s): Probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Follow on formula without probiotics; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants


Options:
A: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics
B: Arm Label: Probiotic; Type: ACTIVE_COMPARATOR; Interventions: Other: Yogurt drink with probiotic bacteria BB12 | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: OTHER; Name: Yogurt drink with probiotic bacteria BB12; Assigned to Arm(s): Probiotic | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Control
C: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic strain | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic strain; Assigned to Arm(s): Probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Mixture of probiotic bacteria and prebiotic oligosaccharide; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol - A Pilot Study
Brief Summary: All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation). We propose a multicenter study in which 700 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Both groups of patients will have the following recorded: ICU and hospital lengths of stay, mortality, total sedative drug use, ICU human resources used, side effects and recall of their ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere. In addition, reducing ICU stay could be economically attractive, as the cost of an ICU day in Canada is approximately $3000.


Options:
A: Intervention Type: PROCEDURE; Name: SAT: Spontaneous Awakening Trial; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: SBT: Spontaneous Breathing Trial; Assigned to Arm(s): N/A
B: Intervention Type: PROCEDURE; Name: Sedation management protocol; Assigned to Arm(s): N/A
C: Arm Label: PS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized Sedation | Arm Label: PS + DI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized sedation, with daily interruption | Intervention Type: PROCEDURE; Name: Protocolized Sedation; Assigned to Arm(s): PS | Intervention Type: PROCEDURE; Name: Protocolized sedation, with daily interruption; Assigned to Arm(s): PS + DI
D: Intervention Type: PROCEDURE; Name: Sedation management strategy; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol - A Pilot Study
Brief Summary: All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation). We propose a multicenter study in which 700 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Both groups of patients will have the following recorded: ICU and hospital lengths of stay, mortality, total sedative drug use, ICU human resources used, side effects and recall of their ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere. In addition, reducing ICU stay could be economically attractive, as the cost of an ICU day in Canada is approximately $3000.


Options:
A: Intervention Type: PROCEDURE; Name: Sedation management strategy; Assigned to Arm(s): N/A
B: Arm Label: PS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized Sedation | Arm Label: PS + DI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Protocolized sedation, with daily interruption | Intervention Type: PROCEDURE; Name: Protocolized Sedation; Assigned to Arm(s): PS | Intervention Type: PROCEDURE; Name: Protocolized sedation, with daily interruption; Assigned to Arm(s): PS + DI
C: Intervention Type: PROCEDURE; Name: SAT: Spontaneous Awakening Trial; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: SBT: Spontaneous Breathing Trial; Assigned to Arm(s): N/A
D: Intervention Type: PROCEDURE; Name: Daily interruption of sedation versus sedation algorithm; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open, Prospective Study to Assess the Efficacy and Safety of FK506 Combined MMF in the Treatment of Class III，IV，V + IV or V + III Lupus Nephritis
Brief Summary: This is an open, prospective study to assess the efficacy and safety of Tacrolimus (FK506) combined with MMF in the treatment of class III, IV, V + IV or V + III lupus nephritis.


Options:
A: Arm Label: Human Umbilical Cord derived MSCs; Type: EXPERIMENTAL; Interventions: Biological: Human Umbilical Cord derived MSCs | Arm Label: Cyclophosphamide; Type: PLACEBO_COMPARATOR; Interventions: Drug: Cyclophosphamide | Intervention Type: BIOLOGICAL; Name: Human Umbilical Cord derived MSCs; Assigned to Arm(s): Human Umbilical Cord derived MSCs | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Cyclophosphamide
B: Arm Label: FK506+MMF; Type: ACTIVE_COMPARATOR; Interventions: Drug: Multitherapy | Intervention Type: DRUG; Name: Multitherapy; Assigned to Arm(s): FK506+MMF
C: Arm Label: Rituximab; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: Mycophenolate mofetil, Drug: Methylprednisolone, Drug: Diphenhydramine, Drug: Acetaminophen, Drug: Prednisone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Mycophenolate mofetil, Drug: Methylprednisolone, Drug: Diphenhydramine, Drug: Acetaminophen, Drug: Prednisone | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Mycophenolate mofetil; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Diphenhydramine; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Acetaminophen; Assigned to Arm(s): Placebo, Rituximab | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Placebo, Rituximab
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: AMG 811 | Arm Label: AMG811; Type: OTHER; Interventions: Drug: AMG 811 | Intervention Type: DRUG; Name: AMG 811; Assigned to Arm(s): AMG811, Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of a Cognitive Intervention for Older Adults
Brief Summary: The purpose of the ACTIVE study was to test if cognitive training interventions could maintain functional independence in elders by improving basic mental abilities, with follow-up assessments through five years.


Options:
A: Arm Label: LLM; Type: EXPERIMENTAL; Interventions: Other: LLM | Arm Label: PTC; Type: EXPERIMENTAL; Interventions: Other: FFA | Arm Label: CTC; Type: EXPERIMENTAL; Interventions: Other: Brain Fitness | Arm Label: Passive; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Other: VideoGrade | Intervention Type: OTHER; Name: LLM; Assigned to Arm(s): LLM | Intervention Type: OTHER; Name: FFA; Assigned to Arm(s): PTC | Intervention Type: OTHER; Name: Brain Fitness; Assigned to Arm(s): CTC | Intervention Type: OTHER; Name: VideoGrade; Assigned to Arm(s): Active
B: Arm Label: Memory Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Training | Arm Label: Reasoning Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Training | Arm Label: Speed of Processing Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Training | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Cognitive Training | Intervention Type: BEHAVIORAL; Name: Cognitive Training; Assigned to Arm(s): Control, Memory Training, Reasoning Training, Speed of Processing Training
C: Arm Label: cognitive training; Type: EXPERIMENTAL; Interventions: Device: CogniFit Personal Coach® | Intervention Type: DEVICE; Name: CogniFit Personal Coach®; Assigned to Arm(s): cognitive training
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: complex cognitive training | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: complex cognitive training | Intervention Type: BEHAVIORAL; Name: complex cognitive training; Assigned to Arm(s): 1, 2

Answer: B